Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Diabetes mellitus4971 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A07661 | 32405181 | J Clin Exp Hepatol | Natural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies. | 2019 | Details |
| A07677 | 32396414 | Aging Male | Non-invasive diagnosis of nonalcoholic fatty liver disease: impact of age and other risk factors. | 2020 | Details |
| A07690 | 32390388 | Clin Lab | Plasma miR-513a-5p as a Potential Biomarker for Diagnosis of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus Patients. | 2020 | Details |
| A07693 | 32389886 | Clin Gastroenterol Hepatol | Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis. | 2020 | Details |
| A07705 | 32384501 | Medicine (Baltimore) | Vitamin D supplementation for nonalcoholic fatty liver disease in type 2 diabetes mellitus: A protocol for a systematic review and meta-analysis. | 2020 | Details |
| A07711 | 32382087 | Sci Rep | Enhanced insulin receptor interaction by a bifunctional insulin-transferrin fusion protein: an approach to overcome insulin resistance. | 2020 | Details |
| A07713 | 32381466 | J Pediatr | Glomerular Hyperfiltration Is Associated with Liver Disease Severity in Children with Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07716 | 32378092 | J Gastrointest Surg | Impact of Type 2 Diabetes on Oncologic Outcomes of Hepatocellular Carcinomas in Non-Cirrhotic, Non-alcoholic Steatohepatitis: a Matched-Pair Analysis. | 2020 | Details |
| A07740 | 32369237 | J Dig Dis | Epidemiology of nonalcoholic fatty liver disease in non-obese populations: Meta-analytic assessment of its prevalence, genetic, metabolic, and histological profiles. | 2020 | Details |
| A07743 | 32368113 | Diabetes Metab Syndr Obes | Common and Unique Factors and the Bidirectional Relationship Between Chronic Kidney Disease and Nonalcoholic Fatty Liver in Type 2 Diabetes Patients. | 2020 | Details |
| A07751 | 32365055 | J Clin Invest | Hepatic Slug epigenetically promotes liver lipogenesis, fatty liver disease, and type 2 diabetes. | 2020 | Details |
| A07764 | 32360826 | Clin Gastroenterol Hepatol | Decreased Quality of Life Is Significantly Associated With Body Composition in Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A07779 | 32356922 | Diabetes Metab Res Rev | Non-alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance. | 2020 | Details |
| A07782 | 32355752 | Ann Transl Med | Shorter leucocyte telomere length as a potential biomarker for nonalcoholic fatty liver disease-related advanced fibrosis in T2DM patients. | 2020 | Details |
| A07791 | 32353589 | Pharmacol Res | 18β-Glycyrrhetinic acid acts through hepatocyte nuclear factor 4 alpha to modulate lipid and carbohydrate metabolism. | 2020 | Details |
| A07796 | 32353039 | PLoS Med | Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies. | 2020 | Details |
| A07799 | 32352682 | Clin Transl Gastroenterol | The Association Between Cholecystectomy, Metabolic Syndrome, and Nonalcoholic Fatty Liver Disease: A Population-Based Study. | 2020 | Details |
| A07802 | 32351294 | World J Gastroenterol | Prevalence, clinical characteristics, risk factors, and indicators for lean Chinese adults with nonalcoholic fatty liver disease. | 2020 | Details |
| A07806 | 32350824 | J Endocrinol Invest | Circulating levels of fetuin-A are associated with moderate-severe hepatic steatosis in young adults. | 2020 | Details |
| A07839 | 32338202 | Curr Med Chem | Regulation of Apolipoprotein B by Natural Products and Nutraceuticals: A Comprehensive Review. | 2021 | Details |
| A07843 | 32337295 | J Diabetes Res | Elevated Serum Level of Cytokeratin 18 M65ED Is an Independent Indicator of Cardiometabolic Disorders. | 2020 | Details |
| A07844 | 32337059 | BMJ Open Gastroenterol | Effectiveness of phosphatidylcholine as adjunctive therapy in improving liver function tests in patients with non-alcoholic fatty liver disease and metabolic comorbidities: real-life observational study from Russia. | 2020 | Details |
| A07847 | 32336033 | J Dig Dis | Non-obese patients with nonalcoholic fatty liver disease may use a lower liver stiffness cut-off to assess fibrosis stages. | 2020 | Details |
| A07848 | 32335964 | J Gastroenterol Hepatol | Dietary patterns are associated with likelihood of hepatic steatosis among US adults. | 2020 | Details |
| A07866 | 32329963 | J Diabetes Investig | Comparison of the effects of three kinds of glucose-lowering drugs on non-alcoholic fatty liver disease in patients with type 2 diabetes: A randomized, open-label, three-arm, active control study. | 2020 | Details |
| A07884 | 32323349 | Aliment Pharmacol Ther | The PNPLA3 rs738409 GG genotype is associated with poorer prognosis in 239 patients with autoimmune hepatitis. | 2020 | Details |
| A07892 | 32319718 | J Intern Med | Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999-2016. | 2020 | Details |
| A07902 | 32316984 | BMC Health Serv Res | Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD). | 2020 | Details |
| A07906 | 32315893 | Nutr Res | Siphonaxanthin, a carotenoid from green algae Codium cylindricum, protects Ob/Ob mice fed on a high-fat diet against lipotoxicity by ameliorating somatic stresses and restoring anti-oxidative capacity. | 2020 | Details |
| A07910 | 32314167 | Indian J Gastroenterol | Metabolic syndrome is not uncommon among lean non-alcoholic fatty liver disease patients as compared with those with obesity. | 2020 | Details |
| A07912 | 32312974 | Nat Commun | Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance. | 2020 | Details |
| A07914 | 32312689 | Best Pract Res Clin Obstet Gynaecol | Implications of abnormal liver function in pregnancy and non-alcoholic fatty liver disease. | 2020 | Details |
| A07928 | 32306654 | Zhonghua Gan Zang Bing Za Zhi | [Diagnosis and treatment strategies for fatty liver when obesity coexists with alcohol consumption]. | 2020 | Details |
| A07941 | 32303531 | BMJ Open Diabetes Res Care | Tissue inhibitor matrix metalloproteinase 1 and risk of type 2 diabetes in a Chinese population. | 2020 | Details |
| A07947 | 32302728 | J Hepatol | Exercise retards hepatocarcinogenesis in obese mice independently of weight control. | 2020 | Details |
| A07979 | 32291277 | Diabetes Care | Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes. | 2020 | Details |
| A07983 | 32290535 | Nutrients | Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases. | 2020 | Details |
| A07988 | 32289180 | Eur J Clin Invest | Prevalence and risk factors of fatty liver in Portuguese adults. | 2020 | Details |
| A07992 | 32285823 | Wiad Lek | Changes in the level of α1-antitrypsin in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A08003 | 32282335 | Am J Gastroenterol | Light-to-Moderate Alcohol Consumption Is Associated With Increased Risk of Type 2 Diabetes in Individuals With Nonalcoholic Fatty Liver Disease: A Nine-Year Cohort Study. | 2020 | Details |
| A08015 | 32280254 | Diabetes Metab Syndr Obes | Low-Magnitude High-Frequency Vibration Decreases Body Weight Gain and Increases Muscle Strength by Enhancing the p38 and AMPK Pathways in db/db Mice. | 2020 | Details |
| A08021 | 32279091 | Mamm Genome | Epigenetic contribution to obesity. | 2020 | Details |
| A08025 | 32278004 | J Hepatol | A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. | 2020 | Details |
| A08034 | 32274348 | J Clin Transl Hepatol | Non-alcoholic Fatty Liver Disease: Growing Burden, Adverse Outcomes and Associations. | 2019 | Details |
| A08038 | 32272865 | Adipocyte | MiR-455 targeting SOCS3 improve liver lipid disorders in diabetic mice. | 2020 | Details |
| A08046 | 32270583 | J Diabetes Investig | Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population. | 2020 | Details |
| A08048 | 32268517 | J Clin Med | Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience. | 2020 | Details |
| A08052 | 32268002 | Diabetes Metab Res Rev | Association of bedtime with the risk of non-alcoholic fatty liver disease among middle-aged and elderly Chinese adults with pre-diabetes and diabetes. | 2020 | Details |
| A08053 | 32267638 | Ned Tijdschr Geneeskd | [Non-alcoholic fatty liver disease; a full-bodied epidemic]. | 2020 | Details |
| A08070 | 32258522 | Transl Gastroenterol Hepatol | Peri-transplant renal dysfunction in patients with non-alcoholic steatohepatitis undergoing liver transplantation. | 2020 | Details |
| A08079 | 32256016 | World J Gastroenterol | Importance of genetic polymorphisms in liver transplantation outcomes. | 2020 | Details |
| A08083 | 32253813 | J Cell Mol Med | Enhanced liver but not muscle OXPHOS in diabetes and reduced glucose output by complex I inhibition. | 2020 | Details |
| A08087 | 32252638 | BMC Gastroenterol | Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study. | 2020 | Details |
| A08093 | 32249283 | J Infect Dis | Nonalcoholic Fatty Liver Disease and the Development of Metabolic Comorbid Conditions in Patients With Human Immunodeficiency Virus Infection. | 2020 | Details |
| A08094 | 32249131 | Semergen | [Descriptive study of hepatic steatosis and associated morbidity in Primary Care. (ESTEATOAP Study)]. | 2020 | Details |
| A08098 | 32245940 | Med Sci Monit | Ganoderma Lucidum Polysaccharides Ameliorates Hepatic Steatosis and Oxidative Stress in db/db Mice via Targeting Nuclear Factor E2 (Erythroid-Derived 2)-Related Factor-2/Heme Oxygenase-1 (HO-1) Pathway. | 2020 | Details |
| A08103 | 32245414 | BMC Gastroenterol | Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study. | 2020 | Details |
| A08110 | 32243868 | Metabolism | Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model. | 2020 | Details |
| A08122 | 32239453 | Endocrine | Insulin resistance is related with liver fibrosis in type 2 diabetic patients with non-alcoholic fatty liver disease proven biopsy and Mediterranean diet pattern as a protective factor. | 2020 | Details |
| A08134 | 32235172 | J Acquir Immune Defic Syndr | Brief Report: Relationship Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in Persons With HIV. | 2020 | Details |
| A08136 | 32232972 | J Diabetes Investig | New perspective on type 2 diabetes, dyslipidemia and non-alcoholic fatty liver disease. | 2020 | Details |
| A08140 | 32231437 | Diabetes Metab Syndr Obes | Dual SGLT1/SGLT2 Inhibitor Phlorizin Ameliorates Non-Alcoholic Fatty Liver Disease and Hepatic Glucose Production in Type 2 Diabetic Mice. | 2020 | Details |
| A08141 | 32231050 | Nutrients | Celiac Disease, Gluten-Free Diet, and Metabolic and Liver Disorders. | 2020 | Details |
| A08160 | 34908794 | Ayu | Efficacy of Sharapunkhadi powder (a polyherbal formulation) and lifestyle modification in the management of nonalcoholic fatty liver disease-A randomized placebo-controlled clinical trial. | 2021 | Details |
| A08185 | 32215009 | Int J Endocrinol | The Dose-Response Relationship between Gamma-Glutamyl Transferase and Risk of Diabetes Mellitus Using Publicly Available Data: A Longitudinal Study in Japan. | 2020 | Details |
| A08192 | 32212193 | Cell Biochem Funct | Knockdown of long non-coding RNA Gm10804 suppresses disorders of hepatic glucose and lipid metabolism in diabetes with non-alcoholic fatty liver disease. | 2020 | Details |
| A08194 | 32211252 | Cureus | Anthropometric Measurements and Lifestyle Characteristics of Individuals with Non-alcoholic Fatty Liver Disease. | 2020 | Details |
| A08201 | 32207583 | Adv Clin Exp Med | Advanced glycation end products derived from serum albumin modification by glucose (AGE-1) reflect clustering of lipid-associated metabolic abnormalities and are decreased in patients treated with acarbose: A cross-sectional study. | 2020 | Details |
| A08212 | 32202088 | World J Mens Health | Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm. | 2020 | Details |
| A08238 | 32190823 | JHEP Rep | Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis. | 2020 | Details |
| A08245 | 32189926 | J Clin Exp Hepatol | Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C Treatment. | 2019 | Details |
| A08263 | 32183383 | Diagnostics (Basel) | Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan. | 2020 | Details |
| A08265 | 32181573 | Liver Int | Endoscopic bariatric and metabolic therapies for non-alcoholic fatty liver disease: Evidence and perspectives. | 2020 | Details |
| A08288 | 32168769 | Int J Mol Sci | Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08289 | 32168372 | Biochem J | Adipocyte lipolysis: from molecular mechanisms of regulation to disease and therapeutics. | 2020 | Details |
| A08291 | 32168133 | J Clin Gastroenterol | Accuracy of Noninvasive Fibrosis Scores to Detect Advanced Fibrosis in Patients With Type-2 Diabetes With Biopsy-proven Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A08296 | 32165250 | J Hepatol | Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping. | 2020 | Details |
| A08300 | 32161545 | Front Pharmacol | Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities. | 2020 | Details |
| A08314 | 32156227 | Curr Pharm Des | Modifiers of Liver-Related Manifestation in the Course of NAFLD. | 2020 | Details |
| A08321 | 32152903 | Indian J Gastroenterol | Epidemiology of non-alcoholic fatty liver disease in Asia. | 2020 | Details |
| A08322 | 32152902 | Indian J Gastroenterol | Treatment of non-alcoholic fatty liver disease - Current perspectives. | 2020 | Details |
| A08325 | 32152478 | Nat Rev Gastroenterol Hepatol | Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. | 2020 | Details |
| A08332 | 32150108 | Medicine (Baltimore) | Effects of high-intensity interval and moderate-intensity continuous aerobic exercise on diabetic obese patients with nonalcoholic fatty liver disease: A comparative randomized controlled trial. | 2020 | Details |
| A08339 | 32148405 | J Ginseng Res | Ginseng-plus-Bai-Hu-Tang ameliorates diet-induced obesity, hepatic steatosis, and insulin resistance in mice. | 2018 | Details |
| A08343 | 32147361 | J Hepatol | Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH. | 2020 | Details |
| A08347 | 32146704 | Adv Ther | Managing NAFLD in Type 2 Diabetes: The Effect of Lifestyle Interventions, a Narrative Review. | 2020 | Details |
| A08351 | 32145387 | Prostaglandins Other Lipid Mediat | Lipocalin-type prostaglandin D2 synthase deletion induces dyslipidemia and non-alcoholic fatty liver disease. | 2020 | Details |
| A08352 | 32145332 | J Ethnopharmacol | Promising therapeutic use of Baccharis trimera (less.) DC. as a natural hepatoprotective agent against hepatic lesions that are caused by multiple risk factors. | 2020 | Details |
| A08359 | 32144419 | J Clin Endocrinol Metab | Glycemic Measures and Development and Resolution of Nonalcoholic Fatty Liver Disease in Nondiabetic Individuals. | 2020 | Details |
| A08366 | 32142998 | Diabetes Metab Syndr | rs7903146 (C/T) polymorphism of Transcription factor 7 like 2 (TCF7L-2) gene is independently associated with non-alcoholic fatty liver disease in Asian Indians. | 2020 | Details |
| A08377 | 32135582 | Gut Liver | Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus. | 2020 | Details |
| A08379 | 32135178 | J Hepatol | Inhibition of PU.1 ameliorates metabolic dysfunction and non-alcoholic steatohepatitis. | 2020 | Details |
| A08380 | 32134732 | J Basic Clin Physiol Pharmacol | Silymarin: not just another antioxidant. | 2020 | Details |
| A08382 | 32132708 | Nature | Glucagon stimulates gluconeogenesis by INSP3R1-mediated hepatic lipolysis. | 2020 | Details |
| A08398 | 32125756 | Liver Int | PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings. | 2020 | Details |
| A08418 | 32118853 | Eur J Gastroenterol Hepatol | A nomogram for discrimination of non-alcoholic fatty liver disease in patients with chronic hepatitis B. | 2021 | Details |
| A08426 | 32115853 | Diabetes Obes Metab | A metabolomics-based molecular pathway analysis of how the sodium-glucose co-transporter-2 inhibitor dapagliflozin may slow kidney function decline in patients with diabetes. | 2020 | Details |
| A08431 | 32113823 | Clin Res Hepatol Gastroenterol | Effect of liraglutide therapy on serum fetuin A in patients with type 2 diabetes and non-alcoholic fatty liver disease. | 2020 | Details |
| A08444 | 32108506 | Scand J Clin Lab Invest | Human apolipoprotein CIII levels; evaluation of three assay methods. | 2020 | Details |
| A08452 | 32105577 | Circ Res | Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases. | 2020 | Details |